EssilorLuxottica Société anonyme Resultados de beneficios anteriores
Pasado controles de criterios 4/6
EssilorLuxottica Société anonyme ha aumentado sus beneficios a una tasa media anual de 26.5%, mientras que los beneficios de la industria de Medical Equipment han experimentado un crecimiento de 5.1% anual. Los ingresos han ido creciendo a una tasa media de 15.1% al año. La rentabilidad financiera de EssilorLuxottica Société anonyme es de 6.2%, y sus márgenes netos son de 9%.
Información clave
26.5%
Tasa de crecimiento de los beneficios
19.4%
Tasa de crecimiento del BPA
| Crecimiento de la industria Medical Equipment | 21.6% |
| Tasa de crecimiento de los ingresos | 15.1% |
| Rentabilidad financiera | 6.2% |
| Margen neto | 9.0% |
| Próxima actualización de resultados | 25 Jul 2024 |
Actualizaciones de resultados anteriores recientes
Recent updates
At €203, Is It Time To Put EssilorLuxottica Société anonyme (EPA:EL) On Your Watch List?
Apr 29
Should You Be Adding EssilorLuxottica Société anonyme (EPA:EL) To Your Watchlist Today?
Apr 16Pinning Down EssilorLuxottica Société anonyme's (EPA:EL) P/E Is Difficult Right Now
Apr 04These 4 Measures Indicate That EssilorLuxottica Société anonyme (EPA:EL) Is Using Debt Reasonably Well
Mar 23Calculating The Fair Value Of EssilorLuxottica Société anonyme (EPA:EL)
Feb 18Getting In Cheap On EssilorLuxottica Société anonyme (EPA:EL) Might Be Difficult
Jan 01With EPS Growth And More, EssilorLuxottica Société anonyme (EPA:EL) Makes An Interesting Case
Dec 17Is There Now An Opportunity In EssilorLuxottica Société anonyme (EPA:EL)?
Dec 04Calculating The Fair Value Of EssilorLuxottica Société anonyme (EPA:EL)
Nov 19Does EssilorLuxottica Société anonyme (EPA:EL) Have A Healthy Balance Sheet?
Sep 25With EPS Growth And More, EssilorLuxottica Société anonyme (EPA:EL) Makes An Interesting Case
Sep 09Should You Think About Buying EssilorLuxottica Société anonyme (EPA:EL) Now?
Aug 24An Intrinsic Calculation For EssilorLuxottica Société anonyme (EPA:EL) Suggests It's 21% Undervalued
Aug 11Does EssilorLuxottica Société anonyme (EPA:EL) Deserve A Spot On Your Watchlist?
Jun 05What Is EssilorLuxottica Société anonyme's (EPA:EL) Share Price Doing?
May 10Is EssilorLuxottica Société anonyme (EPA:EL) A Risky Investment?
Apr 25Here's Why We Think EssilorLuxottica Société anonyme (EPA:EL) Might Deserve Your Attention Today
Feb 21Is It Time To Consider Buying EssilorLuxottica Société anonyme (EPA:EL)?
Jan 25A Look At The Fair Value Of EssilorLuxottica Société anonyme (EPA:EL)
Jan 10These 4 Measures Indicate That EssilorLuxottica Société anonyme (EPA:EL) Is Using Debt Safely
Nov 29Here's Why We Think EssilorLuxottica Société anonyme (EPA:EL) Is Well Worth Watching
Nov 14At €155, Is EssilorLuxottica Société anonyme (EPA:EL) Worth Looking At Closely?
Oct 17Are Investors Undervaluing EssilorLuxottica Société anonyme (EPA:EL) By 36%?
Oct 04Is EssilorLuxottica Société anonyme (EPA:EL) A Risky Investment?
Aug 25Do EssilorLuxottica Société anonyme's (EPA:EL) Earnings Warrant Your Attention?
Aug 11Is It Time To Consider Buying EssilorLuxottica Société anonyme (EPA:EL)?
Jul 01Is EssilorLuxottica Société anonyme (EPA:EL) Trading At A 29% Discount?
Jun 13These 4 Measures Indicate That EssilorLuxottica Société anonyme (EPA:EL) Is Using Debt Safely
Apr 05Is Now The Time To Look At Buying EssilorLuxottica Société anonyme (EPA:EL)?
Mar 15Calculating The Fair Value Of EssilorLuxottica Société anonyme (EPA:EL)
Jan 18EssilorLuxottica Société anonyme (EPA:EL) Seems To Use Debt Rather Sparingly
Dec 23Is It Too Late To Consider Buying EssilorLuxottica Société anonyme (EPA:EL)?
Nov 27Does EssilorLuxottica Société anonyme (EPA:EL) Have A Healthy Balance Sheet?
Sep 11What Does EssilorLuxottica Société anonyme's (EPA:EL) Share Price Indicate?
Aug 22Brokers Are Upgrading Their Views On EssilorLuxottica Société anonyme (EPA:EL) With These New Forecasts
Aug 04EssilorLuxottica Société anonyme (EPA:EL) Just Released Its Half-Year Earnings: Here's What Analysts Think
Aug 03Estimating The Fair Value Of EssilorLuxottica Société anonyme (EPA:EL)
Jul 16Should You Think About Buying EssilorLuxottica Société anonyme (EPA:EL) Now?
May 24EssilorLuxottica Société anonyme (EPA:EL) Seems To Use Debt Quite Sensibly
Apr 12Desglose de ingresos y gastosBeta
Desglose de ingresos y gastos
BetaCómo gana y gasta dinero EssilorLuxottica Société anonyme. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 31 Dec 23 | 25,395 | 2,289 | 11,993 | 593 |
| 30 Sep 23 | 25,373 | 2,314 | 11,997 | 604 |
| 30 Jun 23 | 25,351 | 2,339 | 11,908 | 614 |
| 31 Mar 23 | 24,923 | 2,246 | 11,729 | 607 |
| 31 Dec 22 | 24,494 | 2,152 | 11,642 | 600 |
| 30 Sep 22 | 23,770 | 1,960 | 11,396 | 588 |
| 30 Jun 22 | 23,046 | 1,768 | 11,150 | 575 |
| 31 Mar 22 | 21,433 | 1,608 | 10,193 | 577 |
| 31 Dec 21 | 19,820 | 1,448 | 9,235 | 579 |
| 30 Sep 21 | 18,394 | 1,400 | 8,333 | 575 |
| 30 Jun 21 | 16,967 | 1,351 | 7,430 | 571 |
| 31 Mar 21 | 15,698 | 718 | 7,240 | 562 |
| 31 Dec 20 | 14,429 | 85 | 7,049 | 552 |
| 30 Sep 20 | 14,637 | 40 | 7,209 | 551 |
| 30 Jun 20 | 14,844 | -6 | 7,369 | 550 |
| 31 Mar 20 | 16,117 | 536 | 7,727 | 549 |
| 31 Dec 19 | 17,390 | 1,077 | 8,085 | 548 |
| 30 Sep 19 | 16,215 | 1,151 | 7,629 | 489 |
| 30 Jun 19 | 15,040 | 1,224 | 7,172 | 430 |
| 31 Mar 19 | 12,937 | 1,154 | 6,108 | 310 |
| 31 Dec 18 | 10,833 | 1,083 | 5,044 | 190 |
| 30 Sep 18 | 10,364 | 1,132 | 5,057 | 85 |
| 30 Jun 18 | 9,894 | 1,181 | 5,069 | -21 |
| 31 Mar 18 | 9,539 | 1,111 | 4,605 | 20 |
| 31 Dec 17 | 9,184 | 1,040 | 4,141 | 60 |
| 30 Sep 17 | 8,288 | 913 | 3,011 | 138 |
| 30 Jun 17 | 7,391 | 786 | 1,881 | 216 |
| 31 Mar 17 | 7,253 | 800 | 1,848 | 215 |
| 31 Dec 16 | 7,115 | 813 | 1,814 | 214 |
| 30 Sep 16 | 7,003 | 799 | 1,799 | 216 |
| 30 Jun 16 | 6,891 | 785 | 1,783 | 218 |
| 31 Mar 16 | 6,804 | 771 | 1,755 | 216 |
| 31 Dec 15 | 6,716 | 757 | 1,727 | 214 |
| 30 Sep 15 | 6,507 | 688 | 1,664 | 208 |
| 30 Jun 15 | 6,298 | 618 | 1,601 | 202 |
| 31 Mar 15 | 5,984 | 774 | 1,504 | 195 |
| 31 Dec 14 | 5,670 | 929 | 1,406 | 188 |
| 30 Sep 14 | 5,470 | 956 | 1,326 | 181 |
| 30 Jun 14 | 5,269 | 982 | 1,245 | 173 |
| 31 Mar 14 | 5,167 | 788 | 1,211 | 169 |
| 31 Dec 13 | 5,065 | 593 | 1,177 | 164 |
| 30 Sep 13 | 5,050 | 593 | 1,178 | 162 |
| 30 Jun 13 | 5,035 | 593 | 1,180 | 161 |
Ingresos de calidad: EL tiene ganancias de alta calidad.
Margen de beneficios creciente: Los actuales márgenes de beneficio (9%) de EL son superiores a los del año pasado (8.8%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: En los últimos 5 años, los beneficios de lEL han crecido significativamente en un 26.5% al año.
Acelerando crecimiento: El crecimiento de los beneficios de EL en el último año (6.4%) está por debajo de su media de 5 años (26.5% al año).
Beneficios vs. Industria: El crecimiento de los beneficios de EL en el último año (6.4%) superó al de la industria Medical Equipment -0.04%.
Rentabilidad financiera
Alta ROE: La rentabilidad financiera de EL (6.2%) se considera baja.